US healthcare company CVS Health Corporation (NYSE: CVS) announced on Monday that its board of directors has approved a quarterly dividend of sixty-six and one-half cents (USD0.665) per share on the Common Stock of the Corporation.
The dividend is payable on 1 August 2025, to holders of record on 22 July 2025.
According to CVS Health, as of 31 March 2025 it has more than 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, a pharmacy benefits manager with approximately 88 million plan members, and a dedicated senior pharmacy care business serving more than 800,000 patients per year.
ValiRx subsidiary Inaphaea extends drug repurposing deal with Dominion Biotech
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access
Valneva to supply IXCHIQ vaccine for chikungunya outbreak in La Réunion
ANI Pharmaceuticals announces buyout of royalty obligation for ILUVIEN and YUTIQ
Sirum collaborates with Governor Wes Moore to expand medication access across Maryland